APOA1 and coronary artery disorder: Therefore, the authors concluded that heterozygosity for this apoA-I mutation triggered a detrimental lipoprotein profile which was related to endothelial dysfunction, augmented carotid arterial wall thickening and markedly boosted CAD risk.